We are part of the CSL Limited group of companies. See how we're Driven by Our Promise.
We collaborate with rare disease organizations to promote quality medical care and services.
We offer a variety of support programs and activities for the patients we serve.
We also aim to make sure that nothing holds you back from getting the therapies you need.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
A clinical trial is a research study that is done to find out if medical treatments can improve people’s health.
We work every day as if someone’s life depends on it, because it does.
We manufacture products to treat a number of rare diseases.
Help us deliver on our promise to save lives and protect the health of people.
Diversity and inclusion are top priorities for CSL Behring.
What Gives You Hope for the New Year?
After months of fear and uncertainty, we asked the rare disease community to share what drives them forward.
COVID-19 Vaccines and PI Patients
A good news update for PI patients from Dr. Kate Sullivan: “I can be more optimistic than I have been before.”
What Does It Mean to Be Immunocompromised?
A weakened immune system can be caused by various conditions or treatments.
Expansion Nears Completion in Switzerland
CSL Behring validates new production capacity in Bern.
Keeping the Learning Going in a Global Pandemic
Taiwan Immunoglobulin E-Academy fills a medical education need during COVID-19.
What Are Antibodies?
The Immune Deficiency Foundation’s physician adviser gives a patient-friendly explanation in light of the COVID-19 pandemic.
No Simple Answers on Re-Entering the World
Ask these three questions to assess the risk of COVID-19 for you and your children, says Dr. Kate Sullivan, an immunologist a…
Gene Therapy Collaboration with Seattle Children’s
CSL Behring’s R&D Head: We’re growing our capabilities in gene therapy to improve patients’ lives.
World PI Week 2020
10 Facts to Share About Primary Immunodeficiency (PI)
They Count On You
Primary immunodeficiency patients make a direct plea for plasma donation and social distancing in IPOPI campaign.
Ironman Athlete Takes On Primary Immunodeficiency
The race has changed, but marathoner Stacy Ahearn is still pushing ahead following a rare disease diagnosis at age 40.
Coronavirus: What PID Patients Should Know
Professional associations and advocacy groups dedicated to primary immunodeficiency diseases make a joint, global statement t…
Popular search terms:
Americas
Asia Pacific
Europe
This website uses cookies to improve user experience. By continuing to use this website, you consent to our use of these cookies. To learn more about how we use and manage cookies, see our Privacy Policy and Cookie Policy.
